Anto Biosciences is an early-stage biotechnology startup that develops a multimodal foundation model for microbial communities to predict drug toxicity and therapeutic efficacy
Anto Biosciences is an early-stage biotechnology startup that develops a multimodal foundation model for microbial communities to predict drug toxicity and therapeutic efficacy. The company focuses on making the human gut microbiome computable, allowing pharmaceutical developers to identify and correct microbiome-related causes of clinical drug failures across diverse patient populations.